The ability to accurately measure anterior chamber depth (ACD) is important for angle-closure glaucoma as well as for corrective surgeries for cataract or refractive pathology. Nonaka et al. 1 found that iris convexity was strongly correlated with ACD in patients who had primary angle closure. That is, a shallower ACD increased forward bowing of the iris, resulting in pupillary block. In cataract surgery, ACD measurements are vital because they are used in power calculations for intraocular lenses (IOLs). 2, 3 The phakic IOL is currently one of the more popular surgical options for refractive surgery in highly myopic eyes. However, the use of an anterior chamber IOL can lead to longterm complications of the corneal endothelium, and endothelial cell loss has been reported to be negatively correlated to ACD. 4 At present, many methods to evaluate anterior chamber biometry are available. These include partial coherence interferometry (PCI), 5, 6 Scheimpflug imaging, [7] [8] [9] ultrasound biomicroscopy (UBM), [10] [11] [12] scanning-slit tomography, 12, 13 and ultrasound A-scan. 6, 8 Recently, swept-source anterior segment optical coherence tomography (AS-OCT) has become available, and some studies 14, 15 have evaluated its effectiveness in ocular biometry. However, at present, there is no standardization between devices and it is unknown whether the measurements are interchangeable. To our knowledge, there are no studies that compared ACD measurements obtained from 3-dimensional (3-D) corneal and AS-OCT (CAS-OCT), PCI biometry, and UBM methods. Furthermore, there are no reported comparisons between the true ACD obtained by PCI biometry and measurements from other devices, nor have there been evaluations between 2 different ACD measurements obtained with CAS-OCT.
In this study, we compared ACD measurements obtained using 4 devices: a PCI biometer, a Scheimpflug imager, UBM, and CAS-OCT. We assessed the interdevice agreement to determine whether measurements obtained from the 4 devices can be used interchangeably.
SUBJECTS AND METHODS
Healthy subjects were recruited from Saneikai Tsukazaki Hospital between April and May in 2011. This study received approval from the hospital's institutional review board and was performed according to the tenets of the Declaration of Helsinki. Subjects with ocular disease or previous ocular surgery were excluded from this study.
All patients had a complete ophthalmic examination, including fundoscopy, before measurements were taken in the right eye. In all cases, the ACD measurements were taken in the same order on the same day under controlled dark conditions (20 lux) by 2 experienced operators (E.M., N.N.) as follows: CAS-OCT, PCI biometry, and Scheimpflug imaging. The UBM measurements were taken last by the same experienced operator (S.N.).
Corneal and Anterior Segment Optical Coherence Tomography
The CAS-OCT system in this study (SS-1000 Casia, Tomey Corp.) uses swept-source technology based on 3-D Fourierdomain OCT with a light source of 1310 nm wavelength. The system takes 30 000 A-scans per second. The lateral resolution is 30 mm and the axial resolution, 18 mm. Tissue scans are 16.0 mm in diameter and 6.0 mm deep. Three images were obtained per case. The system was used to measure the ACD and central corneal thickness (CCT) by 2 methods: (1) automatically calculated ACD and CCT (CAS-OCT auto) along an axial line placed from angle to angle with a perpendicular projection that extends from a median point forward through the cornea (Figure 1 ), and (2) manually calculated ACD and CCT (CAS-OCT manual) using calipers along the corneal endothelium in line with the corneal vertex to the anterior surface of the lens (Figure 1) . The ACD and CCT were defined as the mean of 3 images.
Partial Coherence Interferometry Biometer
The PCI biometer used in the study (IOLMaster Carl Zeiss Meditec AG) can take 5 simultaneous ACD measurements; the mean of these readings was used. The biometer uses the principle of PCI to measure the axial length of the globe; however, the ACD is measured by optical principles using a non-PCI method. The PCI biometer uses a slit-beam photographic technique for ACD measurements. A beam of light is projected through the anterior segment of the eye at 33 degrees to the visual axis. The PCI biometer calculates the ACD automatically using a 33-degree tangent and a constant. 9 However, the ACD measured by the PCI biometer includes the CCT; thus, the ACD measurements might be longer than the ACD measurements taken using the other devices. To circumvent this, 2 measurements were taken using the PCI biometer as follows: (1) an automatically calculated ACD and (2) a true ACD, which was defined as the ACD minus the CCT (CAS-OCT manual) because it drew a more direct vertical line to the central cornea than to the CCT (CAS-OCT auto) (Figure 1 ).
Scheimpflug Imaging Device
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Ultrasound Biomicroscopy
The ultrasound biomicroscope used (HiScan, Optikon 2000) is equipped with a 50 MHz transducer. With the subjects supine, topical anesthesia of oxybuprocaine hydrochloride 0.4% (Benoxyl) was applied. The right eye was imaged 3 times using an eyecup filled with methylcellulose 2% and a physiologic salt solution. The ACD was measured manually with calipers from the corneal endothelium in line with the corneal vertex to the anterior surface of the lens. The mean of the 3 measurements was used for subsequent analysis.
Statistical Analysis
Statistical analyses were performed using JMP software (version 6.0.3, SAS Institute, Inc.). Data were expressed as the mean G standard deviation (SD); P values less than 0.05 were considered statistically significant. The statistical significance of interdevice differences was evaluated using 2-way analysis of variance (ANOVA) and post hoc analysis (Tukey-Kramer). In the Bland-Altman analysis, the distribution of measurements was expressed as the mean difference between 2 devices with the SD as well as the 95% limits of agreement (LoA). The 95% LoA were defined as the means G 1.96 SD. The Pearson correlation coefficient (r) between each measurement was also evaluated. Paired t tests were used to compare the difference between the CCT measured by PCI and AS-OCT.
RESULTS
Measurements of 42 patients (18 women, 24 men) were included in the study. The mean age of the subjects was 30.8 G 6.9 years (range 22 to 46 years). The mean spherical equivalent reflection was À3.75 G 2.40 diopters. The mean CCT measurement was 550 G 32 mm using the Scheimpflug device, 535 G 28 mm using CAS-OCT manual, and 528 G 31 mm using CAS-OCT auto. There was no significant difference in CCT measurements between CAS-OCT auto and CAS-OCT manual (PZ1.00, paired t-test). However, there was a significant difference in CCT measurements between the Scheimpflug device and CAS-OCT (P!.001, paired t test).
The mean ACD measurements were 3.72 G 0.23 mm with the PCI biometer, 3.18 G 0.23 mm with PCI true, 3.24 G 0.25 mm with the Scheimpflug device, 3.03 G 0.25 mm with UBM, 3.14 G 0.24 mm with CAS-OCT auto, and 3.12 G 0.24 mm with CAS-OCT manual. Post hoc analysis found significant differences in measurements between the PCI biometer and other measurements, the Scheimpflug device and other measurements, and UBM and other measurements (Figure 2 ).
There were no significant differences between PCI true and CAS-OCT auto (95% confidence interval (CI), À0.002 to 0.081) and or between CAS-OCT auto and CAS-OCT manual (95% CI, À0.016 to 0.067) when analyzed by 2-way ANOVA and post hoc testing. Table 1 shows the Bland-Altman analysis of the differences in the mean ACD measurements and the Pearson correlation coefficients. Good correlation coefficients were observed between all measurements (r Z 0.848 to 0.995). Using Bland-Altman analysis, the width of 95% LoA was smallest with CAS-OCT auto and CAS-OCT manual and largest with UBM and CAS-OCT auto.
There was good agreement between PCI true and the Scheimpflug device, between PCI true and CAS-OCT auto, between PCI true and CAS-OCT manual, and between CAS-OCT auto and CAS-OCT manual (Figure 3) . Figure 4 shows the Bland-Altman plots of the paired differences against mean values for PCI biometer, Scheimpflug device, UBM, and CAS-OCT auto. The calculated mean differences between 2 measurements were not zero; however, almost all distributions of these differences were within the 95% LoA.
DISCUSSION
We believe this is the first study to evaluate the true ACD using the IOLMaster PCI biometer. This is important because this biometer is the most commonly used tool for IOL power calculations worldwide. In this study, the ACD measurements obtained by the PCI biometer were longer than other measurements. Our data contradict results in a previous study by Meinhardt et al., 16 who report an ACD measurement of 3.63 mm using the IOLMaster biometer and of 3.915 mm using the Pentacam Scheimpflug device print & web 4C=FPO Figure 2 . Means of 6 measurements using 4 devices (* Z statistical significance observed using the Tukey-Kramer method; ** Z statistical significance observed between the other 5 measurements using the Tukey-Kramer method; CAS-OCT Z corneal and anterior segment optical coherence tomography; NS Z not significant; PCI Z partial coherence interferometry). 221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275   276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330 (P!.05; n Z 27). Moreover, Elbaz et al. 17 report a mean ACD of 3.014 mm and 3.113 mm, respectively (P!.01; n Z 11). However, in those studies, the ACD was measured from the corneal surface to the anterior surface of the lens with the PCI biometer. If CCT were subtracted from their ACD measurements, their results would also indicate that the IOLMaster PCI biometer measures a longer ACD than the Pentacam Scheimpflug device.
Our findings are in agreement those of with Dinc et al., 18 who measured the ACD from the corneal endothelium to the anterior surface of the lens and found print & web 4C=FPO Figure 3 . The mean and mean G 1.96 SD for PCI true, Scheimpflug, CAS-OCT auto, and CAS-OCT manual ACD measurements (ACD Z anterior chamber depth; CAS-OCT Z corneal and anterior segment optical coherence tomography; PCI Z partial coherence interferometry) (Bland-Altman plots).
a mean ACD of 3.33 mm using the IOLMaster PCI biometer, 2.93 mm using the Pentacam Scheimpflug camera, and 2.98 mm using the Visante OCT device (Carl Zeiss Meditec) (n Z 40). In our study, the IOLMaster PCI measurements were longer than the Pentacam Scheimpflug measurements (3.71 mm versus 3.24 mm; 95% CI, 0.433-0.517), whereas the PCI true measurements were shorter than the Scheimpflug device measurements (3.24 mm versus 3.18 mm; 95% CI, 0.018-0.102). Therefore clinicians should take care when interpreting clinical studies that refer to the "true" ACD with the IOLMaster PCI biometer; the corresponding PCI biometer and PCI biometer (true) measurements provided a longer or a shorter ACD. In our study, the ACD measured by UBM was the shortest of the 6 measurements. This suggests that it is difficult to identify the top of the corneal surface during UBM testing. Moreover, the patient's fixation is not confirmed because there is no internal fixation target. These factors may cause underestimation of the ACD using the UBM method. Previous studies found that the ACD was slightly overestimated by 0.07 to 0.09 mm using Visante AS-OCT compared with UBM in phakic eyes. 19, 20 Piñero et al. 20 concluded that AS-OCT and UBM had good agreement (95% LoA width 0.18 mm) and can be used interchangeably. However in our study, the 95% LoA between CAS-OCT auto and UBM and between CAS-OCT manual and UBM were 0.535 mm and 0.526 mm, respectively. Contradictory to results in previous reports, the agreements in our study were unsatisfactory. We assume this discrepancy was the result of the difference between time-domain OCT and Fourier-domain OCT.
There was no significant difference between PCI biometer true and AS-OCT auto or between CAS-OCT auto and CAS-OCT manual on post hoc analysis. In addition, the Bland-Altman spots showed good agreement. Therefore, we suggest these measurements can be used interchangeably.
On the basis our results we suggest that our data provide an index for comparison of devices that are used to measure ACD as follows: (1) We are confident that the results in our study will be useful to clinicians when comparing ACD measurements taken with these devices. However, the question remains as to which device provides the most accurate ACD measurements. This is a difficult and important problem because each device has a unique mechanism for measuring ACD and as a result, they produce statistically different ACD measurements. On the basis of our results, we believe that most accurate ACD measurements are obtained using the PCI biometer true and CAS-OCT auto measurements because this combination was the only interchangeable pair among the 4 devices. On the other hand, the least accurate ACD was obtained using UBM because of the difficulty in obtaining accurate ACD measurements with this technology.
In this study, we used CCT measurements from the CAS-OCT device but not the Scheimpflug device. This is because Fukuda et al. 15 found that that the Scheimpflug camera yielded significantly higher values than CAS-OCT, scanning-slit topography, and ultrasound pachymetry (P!.0001). This discrepancy may be caused by the mechanism of CCT measurement by the Scheimpflug device, which measures CCT between the air-tear film interface and posterior corneal surface. 21 We predict that CCT measurements using CAS-OCT would be more reliable than Scheimpflug for obtaining real CCT measurements.
Our study was limited in that we used subjects with phakic eyes; thus, our data cannot be directly compared with results in subjects with pseudophakic eyes. Previously, Zhang et al. 22 found greater reproducibility of measurements between AS-OCT and UBM in phakic eyes than in pseudophakic eyes and stated that the measurements with the 2 devices should not be used interchangeably in pseudophakic eyes. Another limitation of our study was that we did not evaluate the possibility of a discrepancy between time-domain OCT and Fourier-domain OCT. Further study of this possibility would contribute to the field.
In conclusion, we measured the ACD using 4 devices and found a significant differences between the IOLMaster PCI, Pentacam Scheimpflug, HiScan UBM, and SS-1000 Casia AS-OCT devices. Although highly correlated, these instruments should not be used interchangeably for the assessment of ACD. The only measurements that can be used interchangeably are the IOLMaster PCI biometer true and CAS-OCT auto and the CAS-OCT auto and CAS-OCT manual. Therefore, based on our data, clinicians should exercise caution when measuring ACD.
WHAT WAS KNOWN
Anterior chamber depth has been recognized as an important ocular biometry measure in angle-closure glaucoma as well as for corrective surgeries.
WHAT THIS PAPER ADDS
We determined that ACD measurements obtained from IOLMaster, Pentacam, Casia CAS-OCT, and HiScan UBM devices differ significantly and are not interchangeable.
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